Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01293565 · ClinicalTrials.gov registry record
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A
A clinical trial, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 27
- Enrollment target
NCT01293565 is a clinical trial that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 27 participants.
The verdict
NCT01293565 has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The overall purpose of this study is to learn more about Hypohidrotic Ectodermal Dysplasia (HED) and to help in identifying treatment opportunities. Several evaluations will be conducted in this study: 1) the number of skin sweat glands you have and their ability to produce sweat; 2) your ability to grow hair; 3) the structure of your face compared to faces of people affected by HED; 4) molds of your teeth to see if and how they are different than people affected by HED.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01293565
The ClinicalTrials.gov registry entry for NCT01293565 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edimer Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01293565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01293565 about?
NCT01293565 is a clinical study titled "Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A". The overall purpose of this study is to learn more about Hypohidrotic Ectodermal Dysplasia (HED) and to help in identifying treatment opportunities. Several evaluations will be conducted in this study: 1) the number of skin sweat glands you have and their ability to produce sweat; 2) your ability to...
What is the current status of trial NCT01293565?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2011-02. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01293565?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.